The price of Adaptive Biotechnologies Corporation (NASDAQ: ADPT) closed at $6.37 in the last session, up 1.43% from day before closing price of $6.28. In other words, the price has increased by $+0.09 from its previous closing price. On the day, 1154266 shares were traded. ADPT stock price reached its highest trading level at $6.58 during the session, while it also had its lowest trading level at $6.14.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
We take a closer look at ADPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.30 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 11 when ADAMS R MARK sold 2,308 shares for $8.63 per share. The transaction valued at 19,918 led to the insider holds 175,361 shares of the business.
ADAMS R MARK sold 817 shares of ADPT for $6,944 on Apr 10. The Chief Operating Officer now owns 177,669 shares after completing the transaction at $8.50 per share. On Mar 27, another insider, GRIFFIN MICHELLE RENEE, who serves as the Director of the company, sold 2,341 shares for $8.49 each. As a result, the insider received 19,878 and left with 20,627 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 920.95M and an Enterprise Value of 586.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.92 while its Price-to-Book (P/B) ratio in mrq is 2.16. Its current Enterprise Value per Revenue stands at 3.18 whereas that against EBITDA is -3.53.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $13.21, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 7.71, while the 200-Day Moving Average is calculated to be 8.37.
According to the various share statistics, ADPT traded on average about 846.37K shares per day over the past 3-months and 890.54k shares per day over the past 10 days. A total of 143.51M shares are outstanding, with a floating share count of 140.66M. Insiders hold about 0.20% of the company’s shares, while institutions hold 89.30% stake in the company. Shares short for ADPT as of Apr 27, 2023 were 6.09M with a Short Ratio of 6.09M, compared to 6.12M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.22% and a Short% of Float of 6.19%.
The company has 10 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.38, while EPS last year was -$0.37. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.25 and low estimates of -$0.32.
Analysts are recommending an EPS of between -$1.12 and -$1.32 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.01, with 10 analysts recommending between -$0.69 and -$1.34.
According to 9 analysts, the current quarter’s revenue is expected to be $45.04M. It ranges from a high estimate of $47.5M to a low estimate of $42M. As of the current estimate, Adaptive Biotechnologies Corporation’s year-ago sales were $43.66M, an estimated increase of 3.20% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $54.21M, an increase of 12.90% over than the figure of $3.20% in the same quarter last year. There is a high estimate of $59.4M for the next quarter, whereas the lowest estimate is $51.12M.
A total of 10 analysts have provided revenue estimates for ADPT’s current fiscal year. The highest revenue estimate was $210.01M, while the lowest revenue estimate was $203.5M, resulting in an average revenue estimate of $207.57M. In the same quarter a year ago, actual revenue was $185.31M, up 12.00% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $260.74M in the next fiscal year. The high estimate is $281.9M and the low estimate is $237.75M. The average revenue growth estimate for next year is up 25.60% from the average revenue estimate for this year.